Diagnosis and management of mitochondrial diseases

Pediatric Clinics of North America

Volumn 49, Issue 1, 2002, Pages 203-219

  Gillis, Lynette ^a   Kaye, Edward ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; ALPHA TOCOPHEROL; ASCORBIC ACID; CARBOXYLIC ACID; CELL NUCLEUS DNA; CREATINE; DICHLOROACETIC ACID; IDEBENONE; KETONE BODY; LACTIC ACID; MENADIONE; MITOCHONDRIAL DNA; RIBOFLAVIN; THIAMINE; UBIQUINONE;

CEREBROSPINAL FLUID; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE MUTATION; GENETIC DISORDER; HUMAN; LEBER CONGENITAL AMAUROSIS; MELAS SYNDROME; MERRF SYNDROME; MUSCLE BIOPSY; NEUROLOGIC DISEASE; PHENOTYPE; REVIEW; SYMPTOMATOLOGY;

EID: 0036155708     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(03)00115-9     Document Type: Review

References (84)

1. A familial visceral myopathy with external ophthalmoplegia and autosomal recessive transmission
2. Incidence of inborn errors of metabolism in British Columbia, 1969-1996
3. Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder
4. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome
5. Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome
6. Mitochondrial disease and cyclic vomiting syndrome
7. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis
8. Single large-scale mitochondrial DNA deletion in a patient with encephalopathy, cardiomyopathy, and prominent intestinal pseudo-obstruction
9. Chronic intestinal pseudoobstruction and ophthalmoplegia in a patient with mitochondrial myopathy
10. Mitochondrial DNA analysis: Polymorphisms and pathogenicity
11. Mitochondrial enteropathy: The primary pathology may not be within the gastrointestinal tract
12. Genetic defects causing mitochondrial respiratory chain disorders and disease
13. Widespread multi-tissue deletions of the mitochondrial genome in the Pearson marrow-pancreas syndrome
14. Mitochondrial DNA rearrangements with onset as chronic diarrhea with villous atrophy
15. Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation
16. Mitochondrial encephalomyopathies: Where next?
17. Mitochondria in neuromuscular disorders
18. 3-Methylglutaconic aciduria associated with Pearson syndrome and respiratory chain defects
19. Mitochondrial respiratory chain defect: A new etiology for neonatal cholestasis and early liver insufficiency
20. Fatal acidosis in a neonate with Pearson syndrome
21. Familial mitochondrial intestinal pseudo-obstruction and neurogenic bladder
22. Correction of increased plasma pyruvate and plasma lactate levels using large doses of thiamine in patients with Kearns-Sayre syndrome
23. Mitochondrial neurogastrointestinal encephalomyelopathy syndrome maps to chromosome 22q13.32-qter
24. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder
25. Defects of intergenomic communication: Where do we stand?
26. Inherited ophthalmoplegia with intestinal pseudo-obstruction
27. Organic aciduria in Pearson syndrome
28. Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate
29. Mechanisms of liver cell injury
30. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p
31. Protean manifestations of mitochondrial diseases: A minireview
32. Detection and characterization of mitochondrial DNA rearrangements in Pearson and Kearns-Sayre syndromes by long PCR
33. Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome
34. Clinical heterogeneity in mitochondrial DNA deletion disorders: A diagnostic challenge of Pearson syndrome
35. Mitochondrial respiratory chain disorders: I. Mitochondrial DNA defects
36. Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone
37. Chronic intestinal pseudoobstruction with myopathy and ophthalmoplegia. A muscular biochemical study of a mitochondrial disorder
38. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA
39. Mtdna depletion with variable tissue expression: A novel genetic abnormality in mitochondrial diseases
40. Pearson's marrow/pancreas syndrome: A histological and genetic study
41. Mitochondrial respiratory chain disorders and the liver
42. Clayton PT: Pearson's syndrome without marrow involvement
43. Clinical presentation of mitochondrial disorders in childhood
44. Clinical aspects of mitochondrial disorders
45. Severe lactic acidosis and neonatal death in Pearson syndrome
46. Clinical implications of duplicated mtDNA in Pearson syndrome
47. Liver involvement in Alpers disease
48. MNGIE: From nuclear DNA to mitochondrial DNA
49. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder
50. Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylase mutations
51. Multiple presentation of mitochondrial disorders
52. Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome
53. Chronic intestinal pseudo-obstruction: Diagnosis and treatment
54. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction
55. Mitochondrial neurogastrointestinal encephalomyopathy: Diagnosis by rectal biopsy
56. Mitochondrial disease
57. Familial visceral myopathy associated with a mitochondrial myopathy
58. Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome
59. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q 10 deficiency
60. Spectrum of mitochondrial DNA deletions in the Pearson marrow-pancreas syndrome
61. Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome
62. Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy
63. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: A preliminary study
64. Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS
65. Late-onset muscle mitochondrial DNA (mtDNA) depletion: Diagnosis by single fiber PCR
66. Pearson marrow pancreas syndrome: A molecular study and clinical management
67. Mitochondrial disorders: Clinical and genetic features
68. Polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudo-obstruction: POLIP syndrome
69. The neuropathology of pseudo-obstruction of the intestine
70. Expanding spectrum of mitochondrial disorders
71. Mitochondria and childhood liver diseases
72. Neonatal presentations of mitochondrial metabolic disorders
73. Disorders of the mitochondria
74. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA
75. Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphologic investigations
76. Ophthalmoplegia, demyelinating neuropathy, leukoencephalopathy, myopathy, and gastrointestinal dysfunction with multiple deletions of mitochondrial DNA: A mitochondrial multisystem disorder in search of a name
77. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity
78. Detection of mitochondrial DNA deletions in human skin fibroblasts of patients with Pearson's syndrome by two-color fluorescence in situ hybridization
79. Characterization of a novel mitochondrial DNA deletion in a patient with a variant of the Pearson marrow-pancreas syndrome
80. Mitochondrial genetics: A paradigm for aging and degenerative diseases?
81. Mitochondrial encephalomyopathies presenting with features of autonomic and visceral dysfunction
82. Defects of mitochondrial DNA